3/12
02:05 pm
nbix
Rating for NBIX
Low
Report
Rating for NBIX
2/25
06:24 am
nbix
Neurocrine Biosciences (NBIX) was upgraded by Wolfe Research to "strong-buy".
Low
Report
Neurocrine Biosciences (NBIX) was upgraded by Wolfe Research to "strong-buy".
2/25
06:24 am
nbix
Neurocrine Biosciences (NBIX) was upgraded by Wolfe Research to "strong-buy".
Low
Report
Neurocrine Biosciences (NBIX) was upgraded by Wolfe Research to "strong-buy".
2/24
08:00 am
nbix
Neurocrine Biosciences (NASDAQ:NBIX) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $160.00 price target on the stock.
Low
Report
Neurocrine Biosciences (NASDAQ:NBIX) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $160.00 price target on the stock.
2/24
08:00 am
nbix
Neurocrine Biosciences (NASDAQ:NBIX) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $160.00 price target on the stock.
Low
Report
Neurocrine Biosciences (NASDAQ:NBIX) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $160.00 price target on the stock.
2/24
07:13 am
nbix
Rating for NBIX
Medium
Report
Rating for NBIX
2/24
07:13 am
nbix
Rating for NBIX
Medium
Report
Rating for NBIX
2/23
04:16 pm
nbix
Neurocrine initiated with an Outperform at Wolfe Research
Low
Report
Neurocrine initiated with an Outperform at Wolfe Research
2/23
04:16 pm
nbix
Neurocrine initiated with an Outperform at Wolfe Research
Low
Report
Neurocrine initiated with an Outperform at Wolfe Research
2/17
02:30 pm
nbix
Rating for NBIX
Low
Report
Rating for NBIX
2/13
09:39 am
nbix
Rating for NBIX
Low
Report
Rating for NBIX
2/13
09:39 am
nbix
Rating for NBIX
Low
Report
Rating for NBIX
2/12
02:30 pm
nbix
Rating for NBIX
Low
Report
Rating for NBIX
2/12
02:30 pm
nbix
Rating for NBIX
Low
Report
Rating for NBIX
2/12
12:45 pm
nbix
Rating for NBIX
Low
Report
Rating for NBIX
2/12
12:45 pm
nbix
Rating for NBIX
Low
Report
Rating for NBIX
2/12
12:06 pm
nbix
Rating for NBIX
Low
Report
Rating for NBIX
2/12
12:06 pm
nbix
Rating for NBIX
Low
Report
Rating for NBIX
2/12
09:41 am
nbix
Rating for NBIX
Medium
Report
Rating for NBIX
2/12
09:41 am
nbix
Rating for NBIX
Medium
Report
Rating for NBIX
2/12
06:10 am
nbix
Rating for NBIX
Medium
Report
Rating for NBIX
2/12
06:10 am
nbix
Rating for NBIX
Medium
Report
Rating for NBIX
1/23
02:34 pm
nbix
Rating for NBIX
Low
Report
Rating for NBIX
1/12
01:14 pm
nbix
Rating for NBIX
Low
Report
Rating for NBIX
1/8
08:02 am
nbix
Neurocrine Biosciences (NASDAQ:NBIX) had its "equal weight" rating reaffirmed by analysts at Morgan Stanley. They now have a $175.00 price target on the stock, up previously from $173.00.
Low
Report
Neurocrine Biosciences (NASDAQ:NBIX) had its "equal weight" rating reaffirmed by analysts at Morgan Stanley. They now have a $175.00 price target on the stock, up previously from $173.00.